703 posters,  63 sessions,  7 topics,  1978 authors 
ePostersLive® by SciGen® Technologies S.A. All rights reserved.

5075
A randomized, double blind, multicenter trial to evaluate clinical effectiveness of 4.4 MHz-radiofrequency compared with ultrasound for patients with subacute low back pain
Session: MP-04b
Thurs, April 19, 3:30-5:00 pm
Uris (Shubert Complex), 6th floor

Please note, medically challenging cases are removed three months after the meeting and scientific abstracts after three years.

Rate

Average: 5 (1 vote)

A randomized, double blind, multicenter trial to evaluate clinical effectiveness of 4.4 MHz-radiofrequency compared with ultrasound for patients with subacute low back pain

Jung Hwan Lee, MD, PhD1, Yong-Taek Lee, MD, PhD2, Hee-Jin Park, MD, PhD3, Jong Geol Do, MD2, Mi Hwa Kim, MS4, Jung Soo Won, BSc1, Sang-Ho Lee, MD, PhD5,  Eun Kyung Kim, MS4, Sang Jun Kim, MD, PhD4

1Department of Physical and Rehabilitation Medicine, Spine Health Wooridul Hospital, 2Department of Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,  3Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine,  4Department of Physical and Rehabilitation Medicine, Stem Cell & Regenerative Medicine Institute, Samsung Medical Center, 5Department of Neurosurgery, Spine Health Wooridul Hospital 

Introduction

Radiofrequency(RF) diathermy has advantages to produce clinical improvements, avoiding more invasive treatment related to serious adverse effects in patients with low back pain (LBP). Thus, development of RF diathermy is useful to provide treatment option in these patients.

Objectives

To investigate the clinical effectiveness and safety of newly developed 4.4 MHz RF diathermy in patients with subacute LBP in comparison with those of ultrasound(US).

Materials & Methods

Eligibility

9 to 70 years old

subacute stage of LBP (1-6 months)

 

Randomization  &  Treatment

118 patients randomly allocated into RF(N=62) vs US group(N=56).

The RF group :  4.4 MHz RF diathermy(HIPER-500®)

The US group : Ultrasonic SUS-2N®

3 times per week for 4 weeks

 

Clinical evaluation

Oswestry Disability Index(ODI)(%),  Numeric rating scale(NRS)

Biering-Sorensen test, Up and go test,

North American Spine Society (NASS) 4 points satisfaction index

Analgesic requirement

Results & Discussion

The RF and the US group accomplished significant reduction of ODI(%) and NRS,  improvement of Biering-Sorensen test,  up and go test at the end of and at 8 weeks after end of treatment.

 

The RF group showed significantly higher proportion of successful reduction of NRS  than the US group

The TF group showed less  requirement of analgesics at 8 weeks after treatment than the US group,

 

Conclusions

Newly developed 4.4 MHz RF diathermy obtained significantly better pain reduction at 8 weeks after treatment and comparable result to US in regard to pain reduction at the end of treatment and other clinical evaluations at the end of and at 8 weeks after treatment.

Enter Poster ID (e.gGoNextPreviousCurrent